Hypoxic pre-conditioning increases the infiltration of endothelial cells into scaffolds for dermal regeneration pre-seeded with mesenchymal stem cells.

Published on Oct 30, 2015in Frontiers in Cell and Developmental Biology5.201
· DOI :10.3389/FCELL.2015.00068
Fernando A. Fierro21
Estimated H-index: 21
(UC Davis: University of California, Davis),
Adam J. O'Neal1
Estimated H-index: 1
(CSUS: California State University, Sacramento)
+ 4 AuthorsJosé T. Egaña19
Estimated H-index: 19
(TUM: Technische Universität München)
Sources
Abstract
Many therapies using mesenchymal stem cells (MSC) rely on their ability to produce and release paracrine signals with chemotactic and pro-angiogenic activity. These characteristics, however, are mostly studied under standard in vitro culture conditions. In contrast, various novel cell-based therapies imply pre-seeding MSC into bio-artificial scaffolds. Here we describe human bone marrow-derived MSC seeded in Integra matrices, a common type of scaffold for dermal regeneration (SDR). We show and measured the distribution of MSC within the SDR, where cells clearly establish physical interactions with the scaffold, exhibiting constant metabolic activity for at least 15 days. In the SDR, MSC secrete VEGF and SDF-1 and induce transwell migration of CD34+ hematopoietic/endothelial progenitor cells, which is inhibited in the presence of a CXCR4/SDF-1 antagonist. MSC in SDR respond to hypoxia by altering levels of angiogenic signals such as Angiogenin, Serpin-1, uPA and IL-8. Finally, we show that MSC-containing SDR that have been pre-incubated in hypoxia show higher infiltration of endothelial cells after implantation into immune deficient mice. Our data show that MSC are fully functional ex vivo when implanted into SDR. In addition, our results strongly support the notion of hypoxic pre-conditioning MSC-containing SDR, in order to promote angiogenesis in the wounds.
📖 Papers frequently viewed together
4 Citations
52 Citations
12 Citations
References38
Newest
#1Elizabeth A. Wahl (TUM: Technische Universität München)H-Index: 5
#2Fernando A. Fierro (UC Davis: University of California, Davis)H-Index: 21
Last. Thilo L. Schenck (TUM: Technische Universität München)H-Index: 19
view all 8 authors...
Mesenchymal stem cells (MSCs) have been shown to improve tissue regeneration in several preclinical and clinical trials. These cells have been used in combination with three-dimensional scaffolds as a promising approach in the field of regenerative medicine. We compare the behavior of human adipose-derived MSCs (AdMSCs) on four different biomaterials that are awaiting or have already received FDA approval to determine a suitable regenerative scaffold for delivering these cells to dermal wounds a...
25 CitationsSource
#1Julie R. BeegleH-Index: 8
#2Kinga LakatosH-Index: 4
Last. Fernando A. FierroH-Index: 21
view all 7 authors...
Mesenchymal stem cells/multipotent stromal cells (MSCs) are promising therapeutics for a variety of conditions. However, after transplantation, cell retention remains extremely challenging. Given that many hypoxic signals are transitory and that the therapeutic administration of MSCs is typically into tissues that are normally hypoxic, we studied the effect of hypoxic preconditioning (HP) prior to new exposure to hypoxia. We show that preincubation for 2 days or more in 1% oxygen reduces serum d...
111 CitationsSource
#1Thilo L. Schenck (TUM: Technische Universität München)H-Index: 19
#2Myra N. Chávez (TUM: Technische Universität München)H-Index: 9
Last. José T. Egaña (TUM: Technische Universität München)H-Index: 19
view all 7 authors...
Insufficient vascularization is considered to be one of the main factors limiting the clinical success of tissue-engineered constructs. In order to evaluate new strategies that aim at improving vascularization, reliable methods are required to make the in-growth of new blood vessels into bio-artificial scaffolds visible and quantify the results. Over the past couple of years, our group has introduced a full skin defect model that enables the direct visualization of blood vessels by transillumina...
9 CitationsSource
#1Laura Shin (RFUMS: Rosalind Franklin University of Medicine and Science)H-Index: 7
#1Laura Shin (RFUMS: Rosalind Franklin University of Medicine and Science)H-Index: 2
Last. Daniel A. Peterson (RFUMS: Rosalind Franklin University of Medicine and Science)H-Index: 65
view all 2 authors...
Mesenchymal stem cells (MSCs) have been investigated as a clinical therapy to promote tissue repair. However, the disappearance of grafted cells soon after engraftment suggests a possible role as initiators of repair rather than effectors. We evaluated the relative contribution of grafted human MSCs and host stem/progenitor cells in promoting wound healing by using a novel asymmetric wound model in normal and impaired healing diabetic (db/db) mice to discriminate between the effect of direct eng...
100 CitationsSource
#1Xiaobing FuH-Index: 1
#2Haihong Li (STU: Shantou University)H-Index: 2
Adult mesenchymal stem cells (MSCs) have the capacity for self-renewal and for differentiating into a variety of cells and tissues. They may leave their niche to migrate to remote tissues and play a critical role in wound repair and tissue regeneration. Because of their multipotency, easy isolation and culture, highly expansive potential, and immunosuppression properties, these cells may be an attractive therapeutic tool for regenerative medicine and tissue engineering. Several studies have indi...
153 CitationsSource
#1Mihaela Crisan (University of Pittsburgh)H-Index: 26
#2Solomon Yap (University of Pittsburgh)H-Index: 5
Last. Bruno Péault (University of Pittsburgh)H-Index: 72
view all 21 authors...
Summary Mesenchymal stem cells (MSCs), the archetypal multipotent progenitor cells derived in cultures of developed organs, are of unknown identity and native distribution. We have prospectively identified perivascular cells, principally pericytes, in multiple human organs including skeletal muscle, pancreas, adipose tissue, and placenta, on CD146, NG2, and PDGF-Rβ expression and absence of hematopoietic, endothelial, and myogenic cell markers. Perivascular cells purified from skeletal muscle or...
3,558 CitationsSource
#1Antonio Uccelli (UniGe: University of Genoa)H-Index: 64
#2Lorenzo Moretta (UniGe: University of Genoa)H-Index: 145
Last. Vito PistoiaH-Index: 70
view all 3 authors...
Mesenchymal stem cells (MSCs) are a heterogeneous subset of stromal stem cells that can be isolated from many adult tissues. They can differentiate into cells of the mesodermal lineage, such as adipocytes, osteocytes and chondrocytes, as well as cells of other embryonic lineages. MSCs can interact with cells of both the innate and adaptive immune systems, leading to the modulation of several effector functions. After in vivo administration, MSCs induce peripheral tolerance and migrate to injured...
3,098 CitationsSource
#1Ivana Rosova (WashU: Washington University in St. Louis)H-Index: 5
#2Mo Dao (WashU: Washington University in St. Louis)H-Index: 2
Last. Jan A. Nolta (UC Davis: University of California, Davis)H-Index: 66
view all 5 authors...
Mesenchymal stem cells (MSC) are adult multipotent cells found in bone marrow, adipose tissue, and other adult tissues. MSC have been shown to improve regeneration of injured tissues in vivo, but the mechanisms remain unclear. Typically, MSC are cultured under ambient, or normoxic, conditions (21% oxygen). However, the physiological niches for MSC in the bone marrow and other sites have much lower oxygen tension. When used as a therapeutic tool to repair tissue injuries, MSC cultured in standard...
697 CitationsSource
#1Richard L. Benton (University of Louisville)H-Index: 21
#2Melissa A. Maddie (University of Louisville)H-Index: 9
Last. Scott R. WhittemoreH-Index: 68
view all 5 authors...
Traumatic spinal cord injury (SCI) results in physical and molecular disruption of the delicate capillary networks within the highly vascularized spinal cord tissue. Temporally, these insults result in subarachnoid hemorrhage, inflammation, and disturbance of the blood—spinal cord barrier (BSCB). The central hemorrhage occupies the gray matter and a variable proportion of adjacent white matter at the epicenter of the injury (Noble and Wrathall, 1985). Disruption of neural and vascular structures...
113 CitationsSource
#1Andrea T. Badillo (UPenn: University of Pennsylvania)H-Index: 9
#2Sophie Chung (UPenn: University of Pennsylvania)H-Index: 1
Last. Kenneth W. Liechty (UPenn: University of Pennsylvania)H-Index: 44
view all 5 authors...
Background. Chronic wounds continue to be a major clinical problem and novel therapeutic approaches are needed. We have previously demonstrated that treatment of diabetic mouse wounds with local application of stromal progenitor cells results in improved healing and increased production of stromal-derived growth factor-1 (SDF-1). We hypothesized that lentiviral-mediated increased production of SDF-1 in the wound environment could also improve diabetic wound healing. Materials and methods. Full-t...
114 CitationsSource
Cited By25
Newest
#1Xiaoyu Han (SJTU: Shanghai Jiao Tong University)H-Index: 1
#2Mingjie Sun (Academy of Medical Sciences, United Kingdom)H-Index: 1
Last. Wenguo Cui (SJTU: Shanghai Jiao Tong University)H-Index: 51
view all 10 authors...
Abstract In the field of bone defect repair, 3D printed scaffolds have the characteristics of personalized customization and accurate internal structure. However, how to construct a well-structured vascular network quickly and effectively inside the scaffold is essential for bone repair after transplantation. Herein, inspired by the unique biological structure of “lotus seedpod”, hydrogel microspheres encapsulating deferoxamine (DFO) liposomes were prepared through microfluidic technology as “lo...
2 CitationsSource
#1Heather Dahlenburg (UC Davis: University of California, Davis)H-Index: 4
#2David Cameron (UC Davis: University of California, Davis)H-Index: 2
Last. Jan A. Nolta (UC Davis: University of California, Davis)H-Index: 66
view all 14 authors...
Huntington's disease (HD) is a fatal autosomal-dominant neurodegenerative disease caused by a trinucleotide CAG repeat expansion of the huntingtin gene (HTT) that affects 1 in every 10 000 individuals in the United States. Our lab developed a novel immune deficient HD mouse strain, the YACNSG, from a commonly used line, the YAC128 mouse, to enable transplantation studies using engineered human cells in addition to studying the impact of the immune system on disease progression. The primary goal ...
Source
#1Thi Van Anh Bui (CityU: City University of Hong Kong)
#2Ji-Won Hwang (Catholic University of Korea)H-Index: 2
Last. Kiwon Ban (CityU: City University of Hong Kong)H-Index: 15
view all 5 authors...
Mesenchymal stem cells (MSCs) represent a population of adult stem cells residing in many tissues, mainly bone marrow, adipose tissue, and umbilical cord. Due to the safety and availability of standard procedures and protocols for isolation, culturing, and characterization of these cells, MSCs have emerged as one of the most promising sources for cell-based cardiac regenerative therapy. Once transplanted into a damaged heart, MSCs release paracrine factors that nurture the injured area, prevent ...
Source
#1Gertraud Eylert (U of T: University of Toronto)H-Index: 2
#2Reinhard Dolp (U of T: University of Toronto)H-Index: 3
Last. Marc G. JeschkeH-Index: 86
view all 10 authors...
Background Multipotent mesenchymal stromal/stem cell (MSC) therapy is under investigation in promising (pre-)clinical trials for wound healing, which is crucial for survival; however, the optimal cell dosage remains unknown. The aim was to investigate the efficacy of different low-to-high MSC dosages incorporated in a biodegradable collagen-based dermal regeneration template (DRT) Integra®. Methods We conducted a porcine study (N = 8 Yorkshire pigs) and seeded between 200 and 2,000,000 cells/cm2...
1 CitationsSource
#1Wenqing Liang (ZJNU: Zhejiang Chinese Medical University)H-Index: 1
#2Xiaozhen Chen (Shaoxing University)H-Index: 1
Last. Xuerong Chen (Shaoxing University)H-Index: 1
view all 7 authors...
Mesenchymal stem cells (MSCs) show homing capacity towards tumor sites. Numerous reports indicate that they are involved in multiple tumor-promoting processes through several mechanisms, including immunosuppression; stimulation of angiogenesis; transition to cancer-associated fibroblasts; inhibition of cancer cell apoptosis; induction of epithelial-mesenchymal transition (EMT); and increase metastasis and chemoresistance. However, other studies have shown that MSCs suppress tumor growth by suppr...
2 CitationsSource
Mesenchymal stromal/stem cells (MSCs) are multipotent adult stem cells that support homeostasis during tissue regeneration. In the last decade, cell therapies based on the use of MSCs have emerged as a promising strategy in the field of regenerative medicine. Although these cells possess robust therapeutic properties that can be applied in the treatment of different diseases, variables in preclinical and clinical trials lead to inconsistent outcomes. MSC therapeutic effects result from the secre...
2 CitationsSource
#1Hsin-ya Yang (UC Davis: University of California, Davis)H-Index: 2
#2Fernando A. Fierro (UC Davis: University of California, Davis)H-Index: 21
Last. Roslyn Rivkah Isseroff (UC Davis: University of California, Davis)H-Index: 58
view all 16 authors...
Diabetic foot ulcers are a major health care concern with limited effective therapies. Mesenchymal stem cell (MSC)-based therapies are promising treatment options due to their beneficial effects of immunomodulation, angiogenesis, and other paracrine effects. We investigated whether a bioengineered scaffold device containing hypoxia-preconditioned, allogeneic human MSCs combined with the beta-adrenergic antagonist timolol could improve impaired wound healing in diabetic mice. Different iterations...
5 CitationsSource
#1Vivian Alonso-Garcia (UFU: Federal University of Uberlandia)H-Index: 1
#2Cutter Chaboya (UC Davis: University of California, Davis)H-Index: 1
Last. Fernando A. Fierro (UC Davis: University of California, Davis)H-Index: 21
view all 11 authors...
For hundreds of indications, mesenchymal stromal cells (MSCs) have not achieved the expected therapeutic efficacy due to an inability of the cells to reach target tissues. We show that inducing high mannose N-glycans either chemically, using the mannosidase I inhibitor Kifunensine, or genetically, using an shRNA to silence the expression of mannosidase I A1 (MAN1A1), strongly increases the motility of MSCs. We show that treatment of MSCs with Kifunensine increases cell migration toward bone frac...
28 CitationsSource
#1Na Song (PRC: China Medical University (PRC))H-Index: 1
#2Martijn Scholtemeijer (Harvard University)H-Index: 1
Last. Khalid Shah (Harvard University)H-Index: 46
view all 3 authors...
Mesenchymal stem/stromal cells (MSCs) are multipotent cells that are emerging as the most promising means of allogeneic cell therapy. MSCs have inherent immunomodulatory characteristics, trophic activity, high in vitro self-renewal ability, and can be readily engineered to enhance their immunomodulatory functions. MSCs affect the functions of most immune effector cells via direct contact with immune cells and local microenvironmental factors. Previous studies have confirmed that the immunomodula...
20 CitationsSource
#1Armin Amirsadeghi (Shiraz University)H-Index: 2
#2Arman Jafari (Shiraz University)H-Index: 6
Last. Mohammad Khorram (Shiraz University)H-Index: 14
view all 6 authors...
A number of drawbacks in skin grafting for wound healing have drawn researchers to focus on skin tissue engineering as an alternative solution. The core idea of tissue engineering is to use scaffolds, cells, and/or bioactive molecules to help the skin to properly recover from injuries. Over the past decades, the field has significantly evolved, developing various strategies to accelerate and improve skin regeneration. However, there are still several limitations that should be addressed. Among t...
8 CitationsSource